Journal Article Summary
The article focuses on chronic spontaneous urticaria (CSU), a condition characterized by recurrent hives and angioedema lasting more than six weeks. Urticaria affects a significant portion of the population, with many experiencing at least one episode in their lifetime. Understanding the diagnosis and treatment of CSU is crucial, as it can severely impact patients' quality of life and may require long-term management strategies.
To gather insights on the management of CSU, Brazilian dermatology experts were surveyed about their diagnostic and therapeutic practices. The study found that most experts agreed with international guidelines on using second-generation antihistamines as the first-line treatment. While these medications are effective, some experts suggested increasing the dosage beyond the licensed amounts in certain cases, despite this being non-licensed. The findings also highlighted the limited availability of certain treatments, like omalizumab, in Brazil's public health system, necessitating adaptations in care.
The article acknowledges several limitations, including the reliance on expert opinion rather than large-scale clinical trials, which may affect the generalizability of the recommendations. Patients should be aware that while antihistamines are generally safe, higher doses may require monitoring for potential side effects. It is essential for individuals with CSU to discuss their treatment options and any concerns with a healthcare professional to ensure safe and effective management of their condition.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Criado Paulo Ricardo, Maruta Celina Wakisaka, Alchorne Alice de Oliveira de Avelar, Ramos Andréa Machado Coelho, Gontijo Bernardo, dos Santos Josemir Belo, Martins Luis Eduardo Agner Machado, Rivitti-Machado Maria Cecília, et al.. Consensus on the diagnostic and therapeutic management of chronic spontaneous urticaria in adults – Brazilian Society of Dermatology*. Anais Brasileiros de Dermatologia 2019. DOI: 10.1590/abd1806-4841.2019940209. PMID: 31166404. PMCID: PMC6544033.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
